Myrtenyl methyl ether is a relatively obscure pinane-derived monoterpene ether with much thinner public literature than myrtenol or myrtenyl acetate. The strongest live evidence supports its chemical identity and occasional analytical detection in essential-oil fingerprinting, especially as a putative marker compound rather than a well-characterized bioactive. AromaForge should treat it as a trace-level aroma analytics constituent with substantial evidence gaps around standalone mechanism, safety, and biological effects.
Chemical identity and composition
PubChem and NIST both identify myrtenyl methyl ether as a bicyclic monoterpene ether with formula C11H18O and InChIKey GMYAZJHVKQKHSD-UHFFFAOYSA-N. Relative to myrtenol, the hydroxyl function is methylated, which changes the constituent class from alcohol to ether and narrows the available safety and metabolism literature.
Aroma and practical use
- Use the recorded minty, fresh, cool, herbal, herbaceous descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2021 GCxGC and gas-chromatography-olfactometry fingerprinting study of Piemonte peppermint essential oil listed myrtenyl methyl ether among the additional untargeted features that were putatively identified as marker chemicals.
A 2021 GCxGC and gas-chromatography-olfactometry fingerprinting study of Piemonte peppermint essential oil listed myrtenyl methyl ether among the additional untargeted features that were putatively identified as marker chemicals.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
A 2026 hyssop review summarized prior hyssop essential-oil literature as including myrtenyl methyl ether at about 1.64-2.1% in some reported compositions, reinforcing that the compound is known mainly from occurrence analytics.
A 2026 hyssop review summarized prior hyssop essential-oil literature as including myrtenyl methyl ether at about 1.64-2.1% in some reported compositions, reinforcing that the compound is known mainly from occurrence analytics.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
Use concerns and concentration limits
Sensitization concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedNo dedicated public constituent-level safety assessment equivalent to the accessible myrtenyl acetate RIFM review was verified for myrtenyl methyl ether in this pass.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
No direct human or animal efficacy studies focused on isolated myrtenyl methyl ether were verified in the reviewed sources.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- No isolated myrtenyl methyl ether pharmacology paper was verified in this pass.
- No constituent-specific safety assessment, dermal limit, or genotoxicity review was located in the reviewed public sources.
- Most accessible evidence is analytical or occurrence-oriented rather than mechanistic.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.